Y-G. Lee - Kangbuk Samsung Hosp, Sungkyunkwan Univ

基本信息

浏览量：0

职业迁徙

个人简介

暂无内容

研究兴趣

论文共 20 篇作者统计合作学者相似作者

按年份排序按引用量排序主题筛选期刊级别筛选合作者筛选合作机构筛选

Nationwide Precision Oncology Pilot Study: KOrean Precision Medicine Networking Group Study of MOlecular Profiling-Guided Therapy Based on Genomic Alterations in Advanced Solid Tumors (KOSMOS) KCSG AL-20-05

T-Y. Kim, S. Y. Kim, J. H. Kim,H. A. Jung,Y. J. Choi,I. G. Hwang, Y. Cha,G-W. Lee,Y-G. Lee,T. M. Kim,S-H. Lee,S. Lee,H. Yun,Y-L. Choi, S. Yoon,S-W. Han,T. W. Kim,D. Y. Zang, J. H. Kang

ANNALS OF ONCOLOGY（2023）

引用0浏览0WOS引用

1324MO CNS Outcomes of Lazertinib Vs Gefitinib in EGFR-mutated Advanced NSCLC: A LASER301 Subset Analysis

R.A. Soo,B.C. Cho,J-H. Kim,M-J. Ahn,K.H. Lee, A. Zimina,S. Orlov,I. Bondarenko,Y-G. Lee, L. Yueh Ni,S.S. Lee,Y.K. Pang,C.H. Fong,J.H. Kang,C.S. Lim,P. Danchaivijitr,H. Lee, S. Park,I. Cicin

Annals of Oncology (2023): S764-S765

引用0浏览0引用

1348P Management of Paresthesia in Patients Treated with Lazertinib: Integrated Analysis of LASER201 and LASER301 Studies

Y-G. Lee, J. S. Ahn,M-J. Ahn,J. H. Kang,R. A. Soo,T. Reungwetwattana,J. C-H. Yang,I. Cicin,D-W. Kim,B. Zaric,H. Go, K. C. Jahng,S. Kim,Y. Lim,K. H. Lee,B. C. Cho

Annals of oncology（2023）

引用0浏览0引用

708P Final Clinical Outcomes of Nationwide Precision Oncology Pilot Study; KOrean Precision Medicine Networking Group Study of MOlecular Profiling Guided Therapy Based on Genomic Alterations in Advanced Solid Tumors (KOSMOS) KCSG AL-20-05

T-Y. Kim, S.Y. Kim,J.H. Kim,H.A. Jung,Y.J. Choi,I.G. Hwang,Y. Cha,G-W. Lee,Y-G. Lee,T.M. Kim,S-H. Lee,S. Lee,H. Yun,Y-L. Choi, S. Yoon,S-W. Han,T.W. Kim,D.Y. Zang,J.H. Kang

Annals of Oncology (2023): S490-S491

引用0浏览0引用

941P Risk Factors for Progressive Disease after Immune Checkpoint Inhibitors (icis) in Advanced Head and Neck Squamous Cell Carcinoma (HNSCC): Who Might Not Be Candidate for ICI

S. Y. Jang,Y-G. Lee, S. H. Chun,J. H. Park,K. U. Park,H. Chang,K-W. Lee,H. R. Kim,S-H. Shin, H. J. An, K-E. Lee,I. G. Hwang,M-J. Ahn,S-B. Kim,B. Keam

Annals of Oncology (2023): S591-S591

引用0浏览0引用

2384P Platinum Rechallenge in the Era of Immune Checkpoint Inhibitor in Locally Advanced/metastatic Urothelial Carcinoma: Multicenter Retrospective Study

E. Kim, J. H. Kim, J. Chu,Y-G. Lee,H-S. Im

Annals of Oncology (2023): S1214-S1214

引用0浏览0引用

OD1-1 Preliminary Results from the KOrean Precision Medicine Networking Group Study of MOlecular Profiling Guided Therapy Based on Genomic Alterations in Advanced Solid Tumors (KOSMOS): KCSG AL-20-05

T-Y. Kim, J.H. Kim,H.A. Jung,Y.J. Choi,I.G. Hwang,Y. Cha,G-W. Lee,Y-G. Lee,M.S. Ahn,T.M. Kim, S-H. Lee, S. Lee,H. Yun,Y-L. Choi,T.W. Kim,D.Y. Zang,J.H. Kang, S.Y. Kim, S. Yoon

ESMO Openno. 6 (2022): 100653-100653

引用0浏览0引用

LBA2 Updated analysis and patient-reported outcomes (PROs) from CITYSCAPE: A randomised, double-blind, phase II study of the anti-TIGIT antibody tiragolumab + atezolizumab (TA) versus placebo + atezolizumab (PA) as first-line treatment for PD-L1+ NSCLC

B.C. Cho,D. Rodriguez-Abreu, M. Hussein,M. Cobo, A. Patel,N. Secen, G. Gerstner,D-W. Kim,Y-G. Lee,W-C. Su, E. Huang,N. Patil,M. Huang,Z. Zhang,X. Wen,D. Mendus,T. Hoang,R. Meng,M.L. Johnson

Annals of Oncology (2021): S1428-S1428

引用17浏览0引用

A Phase Ii Study Of Pdr001 Among Patients With Recurrent And/Or Metastatic Esophageal Squamous Cell Carcinoma: An Interim Analysis Of Km-12

D. K. Lee,S. R. Park, Y. H. Kim,Y-G. Lee,B-C. Ahn,S. M. Lim,H. R. Kim,B. C. Cho,M. H. Hong

ANNALS OF ONCOLOGY（2021）

引用0浏览0引用

PVX-tolerant Potato Development Using a Nucleic Acid-Hydrolyzing Recombinant Antibody

J. -G. Yang,K. -H. Hwang,E. -J. Kil,J. Park,S. Cho,Y. -G. Lee,C. -K. Auh,Y. Rhee,S. Lee

Acta Virologica（2017）

引用1浏览0WOS引用

加载更多

作者统计

合作学者

合作机构

D-Core

合作者
学生
导师

暂无相似学者，你可以通过学者研究领域进行搜索筛选

数据免责声明

页面数据均来自互联网公开来源、合作出版商和通过AI技术自动分析结果，我们不对页面数据的有效性、准确性、正确性、可靠性、完整性和及时性做出任何承诺和保证。若有疑问，可以通过电子邮件方式联系我们：report@aminer.cn